Davies-Johns T, Chidel M, Macklis R M
Department of Radiation Oncology, Cleveland Clinic Foundation, OH 44195, USA.
Semin Urol Oncol. 1999 Feb;17(1):46-54.
Since the early decades of this century, radiation therapy has played an important role in the management of Wilms' tumor. Although in prior years the high radiation doses and eccentric field arrangements used in treatment were responsible for significant late toxicity, examination of long-term survivors and the important information obtained from the National Wilms' Tumor Studies (NWTS) and Societe Internationale d'Oncologie Pediatrique studies have now allowed us to tailor radiation fields and doses to provide high levels of local tumor control with minimal late effects. At present, most patients with NWTS stage III and stage IV tumors are offered radiotherapy as an integral component of their cancer management. Attempts to further refine selection criteria defining those patient groups who will benefit from radiation therapy are ongoing.
自本世纪初以来,放射治疗在肾母细胞瘤的治疗中发挥了重要作用。尽管在过去,治疗中使用的高辐射剂量和偏心野布局导致了显著的晚期毒性,但对长期存活者的检查以及从国家肾母细胞瘤研究(NWTS)和国际小儿肿瘤学会研究中获得的重要信息,现在使我们能够调整放射野和剂量,以在最小化晚期效应的情况下实现高水平的局部肿瘤控制。目前,大多数NWTS III期和IV期肿瘤患者都接受放射治疗,作为其癌症治疗的一个组成部分。目前正在努力进一步完善选择标准,以确定哪些患者群体将从放射治疗中获益。